GE HealthCare Technologies Inc. (GEHC)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $37.54B
Last updated: Nov 17, 2026 at 11:06 AM ET
GE HealthCare Technologies Inc. (GEHC) P/E Ratio & Valuation History
GE HealthCare Technologies (GEHC) trades at 16.9x trailing earnings and 1.7x sales. Its forward P/E is 15.0x. The median P/E across 11 similar companies is 21.9x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 12.7% higher over the next year. Its free cash flow yield is 5.0%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 16.9x |
| Forward P/E | 15.0x |
| Price to sales | 1.7x |
| Price to book | 3.2x |
| EV/EBITDA | 11.6x |
| Price to FCF | 19.9x |
| EV/FCF | 23.6x |
| PEG | 2.2 |
| FCF yield | 5.0% |
Valuation History
Over the 3 year ends shown, its P/E ranged from 17.0x in 2024 to 19.6x in 2023.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $82.02 | 17.9x | 1.8x | 3.6x |
| 2024 | $78.18 | 17.0x | 1.8x | 4.2x |
| 2023 | $77.32 | 19.6x | 1.8x | 5.0x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About GEHC
What is GEHC's forward P/E ratio?
GE HealthCare Technologies has a forward P/E ratio of 15.0x.
Is GEHC stock overvalued?
GNG's valuation label for GEHC is Undervalued. Its P/E of 16.9x compares with a median of 21.9x across 11 similar companies.
What is GEHC's price to sales ratio?
GE HealthCare Technologies has a price to sales ratio of 1.7x.
What is GEHC's PEG ratio?
GE HealthCare Technologies has a PEG ratio of 2.2.
GEHC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors